Article info

Download PDFPDF
Extended report
Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry

Authors

  1. Correspondence to Professor Arthur Kavanaugh, Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, 9500 Gilman Drive, La Jolla, CA 92093-0943, USA; akavanaugh{at}ucsd.edu
View Full Text

Citation

Kavanaugh A, Lee SJ, Curtis JR, et al
Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry

Publication history

  • Received August 7, 2014
  • Revised November 14, 2014
  • Accepted November 15, 2014
  • First published December 3, 2014.
Online issue publication 
May 08, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.